Industry news that matters to you.  Learn more

Forest Laboratories Joins ConvergeHEALTH by Deloitte’s Rapid Learning Network in Collaboration with Intermountain Healthcare to Support Insights into Optimal Patient Care

Reading time: 3 – 4 minutes

ConvergeHEALTH by Deloitte is announcing that Forest Laboratories, Inc. (NYSE:FRX), a leading, fully integrated, specialty pharmaceutical company, and Intermountain Healthcare have entered into a multi-year collaboration to conduct outcomes research leveraging a next generation platform for generating insights into what works for patients. The initial focus of the collaboration is on respiratory disease.

Forest will be part of a collaborative rapid learning network created by Intermountain Healthcare and ConvergeHEALTH that leverages OutcomesMiner, an analytics solution designed to accelerate the development of new treatments, create better therapeutic products and improve patient outcomes while taking costs out of health care delivery.

“At ConvergeHEALTH we believe that the shift to value based, personalized health care is a team sport that not only requires technology and scientific innovation, but new networked R&D models that support a rapid learning health care system, all for the benefit of patients,” said Brett Davis, principal, Deloitte Consulting LLP and general manager of ConvergeHEALTH. “We look forward to Forest joining the ConvergeHEALTH rapid learning network to support this aim as part of a multi-year collaboration with Intermountain Healthcare.”

Dr. Gavin Corcoran, executive vice president, medical affairs, health economics and outcomes research and patient safety at Forest, said “we are excited to work with Intermountain as part of ConvergeHEALTH by Deloitte’s rapid learning network. Intermountain Healthcare has long been a leader in leveraging electronic health information to drive unnecessary variation out of care, while keeping quality high and costs low.”

“This aligns with Forest’s vision of collaborative research with institutes like Intermountain Healthcare enabled by next generation tools like OutcomesMiner, which provides a platform to conduct real world research and insights into patient care,” said Dr. Shailja Dixit, executive director, health economics and outcomes research at Forest. “In particular, we believe this collaboration has the potential to provide unique insights into respiratory disease, which will help optimize use of the appropriate treatment for better patient outcomes.”

Leveraging electronic medical records data, OutcomesMiner will help Forest understand associated outcomes for treatments and filter for sub-populations using phenotypic characteristics and specific medical associations. The solution draws upon Intermountain’s vast repository of electronic health data in supporting analysis around patient and product outcomes under a double-blinded format designed to protect the privacy of personal health information. As part of the collaboration, Forest can engage with Intermountain’s Homer Warner Center for Informatics Research in conducting institutional review board approved follow-on studies to support comparative effectiveness research programs, new product planning activities, health economic and outcomes research and observational insights that support safety analytics and decision making. The Homer Warner Center for Informatics Research is a research facility dedicated to the discovery and implementation of innovative information technologies and leveraging Intermountain’s data for the improvement of clinical care.

“We are excited to work with Forest to tackle important scientific questions that can be best answered by leveraging informatics techniques and real-world evidence from electronic medical records,” said Dr. Peter Haug, director of the Homer Warner Center for Informatics Research at Intermountain Healthcare. “Our goal is to continue to improve our ability to understand the health care needs of our patients and to provide critical insights into the processes of care delivery necessary to optimize outcomes for patients globally.”

Greg Reh, principal, Deloitte Consulting LLP and U.S. leader of Deloitte Consulting’s life sciences practice, said that “by bringing together our leading clients with analytics and research we’ve created together, we are creating a quantum leap in the ability to provide services that address the heart of the business of what our clients need, deliver quality studies, analytics and analysis to understand what works in health care.”

Source: ConvergeHEALTH